Suspension of trading
Sector Chart Forte Biosciences
Stocks
FBRX
US34962G2084
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 26/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 76.99 USD | +0.03% |
|
+0.09% | +182.32% |
| 08-27 | Argenx SE completed the acquisition of Forte Biosciences, Inc.. | CI |
| 08-27 | Argenx Completes Acquisition of Forte Biosciences | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 69.54B | |||||
| 64.97B | |||||
| 26.51B | |||||
| 25.89B | - | ||||
| 25.64B | - |
- Stock Market
- Stocks
- FBRX Stock
- Charts Forte Biosciences
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
